Tianjin Chase Sun Pharmaceutical Co.,Ltd (SHE:300026)
China flag China · Delayed Price · Currency is CNY
3.610
+0.040 (1.12%)
At close: Feb 3, 2026

SHE:300026 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Dec '21 Dec '20
Cash & Equivalents
1,4141,3061,5741,2061,3161,126
Cash & Short-Term Investments
1,4141,3061,5741,2061,3161,126
Cash Growth
26.34%-17.00%30.46%-8.34%16.89%13.95%
Accounts Receivable
2,7852,8252,8923,5463,6942,852
Other Receivables
36.3238.3450.0949.9459.2344.68
Receivables
2,8212,8642,9423,5963,7532,897
Inventory
1,4341,7491,9612,2141,3051,417
Prepaid Expenses
-12.513.2532.1116.77-
Other Current Assets
247.35217.18230.06336.93416.22274.33
Total Current Assets
5,9176,1496,7207,3856,8065,714
Property, Plant & Equipment
3,0063,1493,2423,3222,9012,556
Long-Term Investments
232.78235.58247.62244.03272.82274
Goodwill
675.2675.2692.54716.05716.05799.18
Other Intangible Assets
273.01298.45331.11352.73313.68232.4
Long-Term Accounts Receivable
26.3926.3946.3794.1115.01101.49
Long-Term Deferred Tax Assets
223.96222.17129.29140.56108.16114.48
Long-Term Deferred Charges
384.38386.75402.6327.29311.53343.42
Other Long-Term Assets
19.7422.7723.1477.6862.5144.47
Total Assets
10,75811,16511,83512,66011,60710,180
Accounts Payable
536.44678.15713.45884.77605535.7
Accrued Expenses
10.1299.23184.08444.37519.36321.06
Short-Term Debt
10.1616.2423.18231.47293.79792.84
Current Portion of Long-Term Debt
158.81150.25167.67380.77100.024.55
Current Portion of Leases
-45.2525.8855.0745.86-
Current Income Taxes Payable
68.4319.420.619.8215.1233.04
Current Unearned Revenue
43.263.9776.27208.03137.56132.08
Other Current Liabilities
560.38348.67353.7463.6341.56520.74
Total Current Liabilities
1,3881,6211,5652,6782,0582,340
Long-Term Debt
373.06529.171,2571,3451,458362.03
Long-Term Leases
108.22111.1659.4278.1267.07-
Long-Term Unearned Revenue
61.3265.5662.5662.0467.5574.06
Long-Term Deferred Tax Liabilities
32.6839.5223.233.813.954.22
Other Long-Term Liabilities
-----7.44
Total Liabilities
1,9632,3672,9674,1973,6552,788
Common Stock
3,0043,0043,0043,0043,0043,004
Additional Paid-In Capital
589.89589.89589.49589.49589.49584.28
Retained Earnings
5,0385,0435,1124,6954,1993,642
Comprehensive Income & Other
6.526.834.750.86-19.98-36.43
Total Common Equity
8,6388,6448,7108,2907,7737,194
Minority Interest
157.08154.66157.7172.87179.49197.75
Shareholders' Equity
8,7968,7998,8688,4637,9527,392
Total Liabilities & Equity
10,75811,16511,83512,66011,60710,180
Total Debt
650.24852.071,5332,0911,9651,159
Net Cash (Debt)
763.97454.1240.24-884.45-648.87-33.64
Net Cash Growth
263.46%1028.45%----
Net Cash Per Share
0.370.210.01-0.30-0.22-0.01
Filing Date Shares Outstanding
3,0043,0043,0043,0043,0043,004
Total Common Shares Outstanding
3,0043,0043,0043,0043,0043,004
Working Capital
4,5304,5285,1554,7074,7483,374
Book Value Per Share
2.882.882.902.762.592.39
Tangible Book Value
7,6907,6707,6867,2216,7436,163
Tangible Book Value Per Share
2.562.552.562.402.242.05
Buildings
-1,9861,9881,7301,6511,605
Machinery
-2,5442,5142,1551,8521,665
Construction In Progress
-104.1954.11461.01232.9364.18
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.